Related Experiment Video
Updated: Aug 1, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Pleiotropic effects of statins: do they matter?
1Weill Medical College of Cornell University, New York, New York 10021, USA. amg_editorial@med.cornell.edu
Current Opinion in Lipidology
|August 17, 2001
Summary
Statins, or 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, significantly lower cardiovascular event risk and improve survival by reducing coronary heart disease deaths. Their complex mechanisms, including pleiotropic effects beyond cholesterol reduction, are under active investigation.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Biochemistry
Background:
- Statins are widely used to reduce cardiovascular events and mortality.
- Their primary mechanism involves lowering LDL-cholesterol levels.
- Statins possess complex vascular effects beyond lipid modification.
Purpose of the Study:
- To investigate the pleiotropic, or non-lipid-modifying, effects of statin therapy.
- To understand the contribution of these pleiotropic effects to overall clinical benefits.
Main Methods:
- Review of primary and secondary prevention trials.
- Analysis of statin effects on endothelial function, inflammation, coagulation, and plaque stability.
Main Results:
- Statins demonstrate efficacy in both primary and secondary cardiovascular prevention.
- Evidence suggests statins impact endothelial function, inflammation, coagulation, and plaque stability.
- The precise contribution of non-lipid effects to clinical outcomes is under investigation.
Conclusions:
- Statins offer significant cardiovascular benefits, partly through mechanisms independent of LDL-cholesterol reduction.
- Further research is needed to elucidate the role of pleiotropic effects in statin therapy.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...